Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
82.8M
-
Number of holders
-
230
-
Total 13F shares, excl. options
-
56.4M
-
Shares change
-
-10.8M
-
Total reported value, excl. options
-
$263M
-
Value change
-
-$55.7M
-
Put/Call ratio
-
0.69
-
Number of buys
-
107
-
Number of sells
-
-109
-
Price
-
$4.67
Significant Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q2 2024
277 filings reported holding EDIT - Editas Medicine, Inc. - Common Stock as of Q2 2024.
Editas Medicine, Inc. - Common Stock (EDIT) has 230 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56.4M shares
of 82.8M outstanding shares and own 68.12% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (8.03M shares), BlackRock Inc. (7.78M shares), Deep Track Capital, LP (6M shares), STATE STREET CORP (4.59M shares), MILLENNIUM MANAGEMENT LLC (2.46M shares), DIMENSIONAL FUND ADVISORS LP (2.35M shares), GEODE CAPITAL MANAGEMENT, LLC (1.97M shares), Pictet Asset Management Holding SA (1.43M shares), GOLDMAN SACHS GROUP INC (1.22M shares), and Woodline Partners LP (970K shares).
This table shows the top 230 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.